Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hereditary nonpolyposis colorectal cancer syndrome

Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part 1. The utility of immunohistochemistry. J Mol Diagn. 2008 10 293-300. [Pg.536]

Lu KH, Dinh M, Kohlmann W, et al. Gynecologic cancer as a sentinel cancer for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005 105 569-574. [Pg.761]

Hereditary breast-ovarian cancer syndrome (HBOC) accounts for the vast majority (85%-90%) of all hereditary ovarian cancers [5]. The site-specific ovarian cancer syndrome with only ovarian cancer accounts for 10%-15% of hereditary ovarian cancers. In hereditary nonpolyposis colorectal cancer syndrome (HNPCC), which is also known as Lynch syndrome II, patients present with colon, endometrial, breast, ovarian and other cancers [6],... [Pg.234]

Chung DC, Rustgi AK (2003). The hereditary nonpolyposis colorectal cancer syndrome genetics and clinical implications. Ann Intern Med 138 660-570... [Pg.262]

Lynch, H. T., and Smyrk, T. 1996. Hereditary nonpolyposis colorectal cancer (Lynch Syndrome) An updated review. Cancer 78 1149-1167. [Pg.329]

Inherited CRC syndromes initiate as a result of an inherited mutation in one of the genes involved in the CIN or MSI pathway. Although several CRC syndromes exist, the two most common are famUial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC), Most interestingly, tumors in FAP kindreds and tumors displaying CIN more frequently are found in the distal part of the colon, whereas tumors in HNPCC families and tumors displaying MSI more commonly occur in the proximal part of the colon. ... [Pg.1510]

Vasen HFA, Watson P, Mecklin JP, Lynch HT and The International Collaborative Group on HNPCC. New clinical criteria for Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999 116 1453-6. [Pg.1536]

Colon cancer is one of the main causes of cancer mortality in Western societies [150]. About 15-20% of colorectal tumors are causally determined by inheritance of genetic alterations such as the hereditary nonpolyposis colorectal cancer (HNPCC) and the syndrome familial adenomatous polyposis (FAP) [151,152]. Microsatellite instability, a characteristic of HNPCC, is caused by mutations in the genes essential for mismatch repair. The loss of mismatch repair has several consequences most crucially, the loss of proofreading and correction of small deletions and insertions. FAP is a rare autosomal dominant syndrome caused by an inherited mutation in the APC gene. The disease is characterized by the development of multiple colorectal adenomas, numbering from a few polyps to several thousands. [Pg.253]

Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 96 261-268. [Pg.57]

The tumors may arise sporadically or in patients with the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome.Current experience is too limited to determine their biologic behavior and prognosis however, in one study, the patients were found to have an improved survival rate relative to those with DAs. ° Immunohistochemically, the epithelioid cells are labeled by antibodies to cytokeratins whereas trypsin, chymotrypsin, lipase, chromogranin, and synaptophysin are usually negative. CD3 antibody highlights the presence of numerous intratumoral T lymphocytes. Rare examples also contain Epstein-Barr virus RNA. ... [Pg.548]

Lynch HT, Lanspa S, Smyrk T, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I II). Genetics, pathology, natural history, and cancer control. Part I. Cancer Genet Cytogenet. 1991 53 143-160. [Pg.753]

Ollikainen M, Abdel-Rahman WM, Moisio AL, et al. Molecular analysis of familial endometrial carcinoma A manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome J Clin Oncol. 2005 23 4609-4616. [Pg.753]

Hampel H, Frankel W, Panescu J, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006 66 7810-7817. [Pg.753]


See other pages where Hereditary nonpolyposis colorectal cancer syndrome is mentioned: [Pg.1344]    [Pg.144]    [Pg.1140]    [Pg.810]    [Pg.509]    [Pg.530]    [Pg.745]    [Pg.191]    [Pg.7]    [Pg.424]    [Pg.179]    [Pg.784]    [Pg.271]    [Pg.574]    [Pg.278]   


SEARCH



Cancer hereditary

Colorectal cancer

Colorectal cancer hereditary nonpolyposis

Colorectal cancer nonpolyposis

Hereditary

Hereditary nonpolyposis cancer

Hereditary nonpolyposis colorectal cancer syndrome HNPCC)

Hereditary syndrome

© 2024 chempedia.info